Cargando…
Bioindustry ethics /
This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston :
Elsevier Academic Press,
�2005.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn162572851 | ||
| 003 | OCoLC | ||
| 005 | 20231117014932.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070806s2005 ne ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d OCLCQ |d N$T |d YDXCP |d MERUC |d UBY |d E7B |d IDEBK |d OCLCQ |d NLGGC |d OCLCQ |d OCLCF |d AZK |d LOA |d OCLCO |d OCLCA |d AGLDB |d COCUF |d OCLCO |d MOR |d PIFAG |d OCLCQ |d CASUM |d OCLCO |d OCLCA |d OCL |d WRM |d VNS |d OCLCO |d D6H |d OCLCO |d VTS |d OCLCO |d CHVBK |d CRU |d OCLCA |d OCLCQ |d OCLCO |d VT2 |d OCLCQ |d WYU |d OCLCA |d STF |d OCLCO |d LEAUB |d OCLCO |d M8D |d OCLCO |d OCLCA |d S2H |d OCLCO |d OCLCQ |d OCLCO |d INARC |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 154363149 |a 441784716 |a 505077954 |a 648300386 |a 823826885 |a 823896265 |a 824088426 |a 824134856 |a 961641957 |a 962622076 | ||
| 020 | |a 9780123693709 | ||
| 020 | |a 0123693705 | ||
| 020 | |a 9780080492513 |q (electronic bk.) | ||
| 020 | |a 0080492517 |q (electronic bk.) | ||
| 020 | |a 1281005339 | ||
| 020 | |a 9781281005335 | ||
| 035 | |a (OCoLC)162572851 |z (OCoLC)154363149 |z (OCoLC)441784716 |z (OCoLC)505077954 |z (OCoLC)648300386 |z (OCoLC)823826885 |z (OCoLC)823896265 |z (OCoLC)824088426 |z (OCoLC)824134856 |z (OCoLC)961641957 |z (OCoLC)962622076 | ||
| 050 | 4 | |a HD9999.B442 |b B542 2005eb | |
| 060 | 4 | |a 2006 G-784 | |
| 060 | 4 | |a WB 60 |b B615495 2005 | |
| 072 | 7 | |a BUS |x 008000 |2 bisacsh | |
| 072 | 7 | |a HPGM |2 bicssc | |
| 082 | 0 | 4 | |a 174/.96606 |2 22 |
| 245 | 0 | 0 | |a Bioindustry ethics / |c David L. Finegold [and others]. |
| 260 | |a Amsterdam ; |a Boston : |b Elsevier Academic Press, |c �2005. | ||
| 300 | |a 1 online resource (xi, 368 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics. | ||
| 505 | 0 | |a Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes. | |
| 500 | |a Includes index. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Biotechnology industries |x Moral and ethical aspects |v Case studies. | |
| 650 | 0 | |a Pharmaceutical industry |x Moral and ethical aspects |v Case studies. | |
| 650 | 0 | |a Business ethics |x Moral and ethical aspects |v Case studies. | |
| 650 | 0 | |a Bioethics. | |
| 650 | 0 | |a Business ethics |v Case studies. | |
| 650 | 1 | 2 | |a Bioethics |0 (DNLM)D001675 |
| 650 | 2 | 2 | |a Biotechnology |x ethics |0 (DNLM)D001709Q000941 |
| 650 | 2 | 2 | |a Drug Industry |x ethics |0 (DNLM)D004345Q000941 |
| 650 | 2 | 2 | |a Ethics, Business |0 (DNLM)D040861 |
| 650 | 6 | |a Bio-industries |0 (CaQQLa)201-0136258 |x Aspect moral |0 (CaQQLa)201-0374162 |v �Etudes de cas. |0 (CaQQLa)201-0376950 | |
| 650 | 6 | |a Industrie pharmaceutique |0 (CaQQLa)201-0042410 |x Aspect moral |0 (CaQQLa)201-0374162 |v �Etudes de cas. |0 (CaQQLa)201-0376950 | |
| 650 | 6 | |a Morale des affaires |0 (CaQQLa)201-0041527 |v �Etudes de cas. |0 (CaQQLa)201-0376950 | |
| 650 | 6 | |a Morale des affaires |0 (CaQQLa)201-0041527 |x Aspect moral |0 (CaQQLa)201-0374162 |v �Etudes de cas. |0 (CaQQLa)201-0376950 | |
| 650 | 6 | |a Bio�ethique. |0 (CaQQLa)201-0045491 | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Business Ethics. |2 bisacsh | |
| 650 | 7 | |a Business ethics |2 fast |0 (OCoLC)fst00842675 | |
| 650 | 7 | |a Bioethics |2 fast |0 (OCoLC)fst00832038 | |
| 650 | 7 | |a Biotechnology industries |x Moral and ethical aspects |2 fast |0 (OCoLC)fst00832809 | |
| 650 | 7 | |a Pharmaceutical industry |x Moral and ethical aspects |2 fast |0 (OCoLC)fst01060163 | |
| 655 | 2 | |a Case Reports |0 (DNLM)D002363 | |
| 655 | 7 | |a Case studies |2 fast |0 (OCoLC)fst01423765 | |
| 655 | 7 | |a Case studies. |2 lcgft | |
| 655 | 7 | |a �Etudes de cas. |2 rvmgf |0 (CaQQLa)RVMGF-000001726 | |
| 700 | 1 | |a Finegold, David. | |
| 776 | 0 | 8 | |i Print version: |t Bioindustry ethics. |d Amsterdam ; Boston : Elsevier Academic Press, �2005 |z 0123693705 |z 9780123693709 |w (DLC) 2005040638 |w (OCoLC)57751490 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780123693709 |z Texto completo |